Pulmonary arterial hypertension (PAH) can be a challenging complication to manage during pregnancy; women with PAH who are ...

Recent cuts to federal grants are set to have a widespread impact across numerous scientific and medical studies.

Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...

The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but ...

Annie Antar, MD, PhD, discusses the association between the symptoms of long COVID and HIV status. Annie Antar, MD, PhD, Johns Hopkins Medicine, spoke about how the likelihood of long COVID symptoms ...

Elizabeth Jones, MD, FAAD, Thomas Jefferson University Hospitals, highlights the continued relevance of older, generic dermatologic therapies despite the availability of newer, targeted treatments.

Barry Byrne, MD, PhD, pediatric cardiologist, director, Powell Gene Therapy Center, joined the University of Florida in 1997. Having taken on educational, clinical, and research roles alike, he is ...

Adeno-associated virus (AAV)–mediated gene therapy was one of the focal points of this year's Muscular Dystrophy Association conference. Here, Barry Byrne, MD, PhD, University of Florida, speaks to ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

Multiparametric quantitative MRI could potentially help differentiate between Duchenne muscular dystrophy and Becker muscular dystrophy early and improve the management of these conditions.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Toon Van Gorp, MD, PhD, is a professor of gynecologic oncology at the University of Leuven. The final analysis showed similar overall survival, progression-free survival, and objective response rates, ...